PRONORAN IN MONOTHERAPY AND COMBINED TREATMENT FOR PARKINSON’S DISEASE
Pronoran is one of the effective dopamine receptor agonists. It may be successfully used for the therapy of both early- and late-stage Parkinson’s disease, by improving day-to-day motor activity in patients and their quality of life.